The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subcutaneous epcoritamab + R-DHAX/C in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) eligible for autologous stem cell transplant (ASCT): Preliminary phase 1/2 results.
 
Pau Abrisqueta
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen
 
Lorenzo Falchi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Genmab; Roche/Genentech
Research Funding - Genmab; Roche
 
Tycel Jovelle Phillips
Honoraria - Lymphoma & Myeloma Connect; Seagen
Consulting or Advisory Role - ADC Therapeutics; Bayer; Celgene; Curis; Genentech; Genmab; Gilead Sciences; Incyte; Kite/Gilead; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
 
Sven De Vos
No Relationships to Disclose
 
Marcel Nijland
Consulting or Advisory Role - Genmab
Research Funding - Roche; Takeda
 
Fritz Offner
No Relationships to Disclose
 
Irina Bykhovski
Employment - Genmab
 
Jun Wu
Employment - Abbvie
 
Liwei Wang
Employment - Genmab
 
Ali Rana
Employment - Genmab
 
Raul Cordoba
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Janssen; Kite/Gilead; Kyowa-Kirin; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche